News for Burzynski Research Institute, Inc. (BZYR)

Published at

Sep 25, 2023 4:00 PM

by globenewswire.com

mixed

mixed

Ependymoma Market; Increasing Incidence Rates and Advancements in Medical Imaging to Fuel Market Growth – By PMI

Ependymoma Market [2022-2030] Research Report Analysis and Outlook Insights | Latest Updated Report | The Ependymoma Market research report analyses the...

LLY.MX LLY.DE LLY.BA LLY LILY34.SA AMGN.MX AMGN.BA AMGN AMG.DE 0Q1G.L CLRB BZYR

Read more →
Published at

May 24, 2021 11:19 PM

by sec.gov

positive

positive

EDGAR Filing Documents for 0001104659-21-071200

Mailing Address 9432 KATY FREEWAY HOUSTON TX 77055 Business Address 12000 RICHMOND AVE HOUSTON TX 77082 (713) 335-5697 CIK : 0000724445 (see all company filin...

BZYR

Read more →
Published at

Apr 15, 2021 10:22 PM

by globalbankingandfinance.com

positive

positive

Von Hippel-Lindau Market is Expected to Witness Rapid Growth by 2030 | Astellas US Holding, Inc., Advantagene, Inc, Burzynski Research Institute, Inc., Cellectar Biosciences, Inc., Direct Therapeutics

Von Hippel-Lindau is an autosomal disease can cause malignant tumor due to the mutation in the Von Hippel-Lindau gene. Von Hippel-Lindau is one of the risk

CLRB BZYR

Read more →
Published at

Jan 14, 2021 10:16 PM

by sec.gov

positive

positive

EDGAR Filing Documents for 0001104659-21-004240

Mailing Address 9432 KATY FREEWAY HOUSTON TX 77055 Business Address 12000 RICHMOND AVE HOUSTON TX 77082 (713) 335-5697 CIK : 0000724445 (see all company filin...

BZYR

Read more →

News for Burzynski Research Institute, Inc. (BZYR)

Ependymoma Market; Increasing Incidence Rates and Advancements in Medical Imaging to Fuel Market Growth – By PMI

EDGAR Filing Documents for 0001104659-21-071200

Von Hippel-Lindau Market is Expected to Witness Rapid Growth by 2030 | Astellas US Holding, Inc., Advantagene, Inc, Burzynski Research Institute, Inc., Cellectar Biosciences, Inc., Direct Therapeutics

EDGAR Filing Documents for 0001104659-21-004240